V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014348 | 260009684 | 1.73 | 59.7 | Curative (C) | 2017-05-24 | 2017-05-31 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260029247 | GEMCITABINE |
| 260014349 | 260009684 | 1.5 | 48.9 | Palliative (P) | 2018-03-09 | 2018-03-09 | GDP | 02 | N | 260029247 | CHLORAMBUCIL + RITUXIMAB |
| 260014350 | 260009685 | 1.57 | 94.2 | Curative (C) | 2018-03-06 | 2018-03-06 | UKALL14- Intens/CNS Proph | N | N | 260029256 | OBINUTUZUMAB |
| 260014351 | 260014604 | 0 | null | Palliative (P) | 2018-06-06 | 2018-06-12 | CODOX M | N | N | 260029259 | ESHAP R |
| 260014352 | 260009688 | 1.66 | 102 | Curative (C) | 2016-03-02 | 2016-03-03 | ESHAP R | 2 | N | 260029259 | CHLORAMBUCIL + RITUXIMAB |
| 260014353 | 260009688 | 1.7 | 78.05 | Adjuvant (A) | 2017-04-21 | 2017-04-30 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | N | 260029259 | LENALIDOMIDE |
| 260014354 | 260009690 | 1.6 | 97 | Palliative (P) | 2018-01-04 | 2018-01-07 | CYCLOPHOSPHAMIDE | 2 | N | 260029266 | CARBO + THIOTEPA + TOPOTECAN |
| 260014355 | 260009690 | 1.7 | 85 | Curative (C) | 2014-08-10 | 2014-08-12 | PMitCEBO-R | N | N | 260029266 | ESHAP |
| 260014356 | 260009690 | 1.77 | 95 | Adjuvant (A) | null | 2018-04-08 | Bortezomib + Cyclophos + Dex | N | N | 260029266 | OFATUMUMAB |
| 260014357 | 260009690 | 1.72 | 90.7 | Curative (C) | 2018-01-20 | 2018-01-20 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260029266 | DHAP - R |
| 260014358 | 260014607 | 1.62 | 56.6 | Curative (C) | 2016-02-24 | 2016-06-08 | IMATINIB | 02 | N | 260029297 | GDP |
| 260014359 | 260014607 | null | 85 | Curative (C) | 2016-12-13 | 2016-12-13 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | N | 260029297 | PMITCEBO |
| 260014360 | 260014607 | 1.8 | 72.4 | Curative (C) | 2016-11-14 | 2017-03-27 | IMATINIB | 02 | N | 260029297 | METHOTREXATE |
| 260014361 | 260014608 | 1.73 | 53.6 | Adjuvant (A) | 2017-10-02 | 2018-06-15 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 260029313 | CISPLATIN |
| 260014362 | 260018795 | 1.74 | 67.8 | Curative (C) | 2016-07-31 | 2016-09-01 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260029321 | IVADO |
| 260014363 | 260009697 | 1.81 | 47.3 | Palliative (P) | null | 2018-10-24 | CYCLOPHOSPHAMIDE | null | null | 260029325 | GEMCITABINE + PACLITAXEL |
| 260014364 | 260009698 | 1.62 | 66 | Adjuvant (A) | 2018-05-07 | 2018-05-15 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | N | 260029330 | ESHAP |
| 260014365 | 260009700 | 1.75 | 60.4 | Curative (C) | 2015-04-05 | 2015-05-02 | CYCLOPHOSPHAMIDE | null | null | 260029334 | VIP |
| 260014366 | 260009701 | 1.64 | null | Adjuvant (A) | null | 2017-08-16 | Alemtuzumab cond (RI ALLO CAMP100) | null | null | 260029335 | METHOTREXATE HIGH DOSE |
| 260014367 | 260009701 | 1.54 | null | Palliative (P) | 2014-04-21 | 2014-04-24 | R Chlorambucil | 02 | N | 260029335 | CVP R + GEMCITABINE |
| 260014368 | 260014611 | null | 51.4 | Adjuvant (A) | null | 2016-03-09 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 260029342 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014369 | 260014611 | 1.73 | 100 | Palliative (P) | 2013-11-17 | 2013-11-27 | Cytarabine HD + Methotrexate HD | N | N | 260029342 | PACLITAXEL |
| 260014370 | 260009703 | 1.84 | 147 | Curative (C) | 2014-01-20 | 2014-02-01 | CVP | 2 | N | 260029348 | GEMCITABINE |
| 260014371 | 260009706 | 1.83 | 65.3 | Curative (C) | 2014-06-29 | 2014-07-06 | Obinutuzumab | N | N | 260029348 | ENZALUTAMIDE |
| 260014372 | 260009707 | 1.7 | 64.7 | Palliative (P) | 2016-09-12 | 2016-09-12 | De Angelis (Modified) | 02 | N | 260029356 | R-EPOCH |
| 260014373 | 260009709 | 1.66 | null | Curative (C) | 2014-12-01 | 2014-12-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | n | 260029361 | GEMCITABINE |
| 260014374 | 260009711 | 1.65 | null | Curative (C) | 2016-07-20 | 2016-07-20 | ABVD | N | N | 260029363 | ETOPOSIDE + IFOSFAMIDE + MTX |
| 260014375 | 260014616 | 1.83 | 66.8 | Curative (C) | 2018-10-10 | 2018-10-10 | Irinotecan | N | N | 260029364 | CHLORAMBUCIL + RITUXIMAB |
| 260014376 | 260014616 | 1.55 | 98.9 | Curative (C) | 2013-08-11 | 2013-10-12 | Irinotecan + Modified De Gramont | null | N | 260029364 | DE ANGELIS |
| 260014377 | 260017002 | 1.69 | 91.5 | Palliative (P) | 2019-07-08 | 2019-07-09 | Gemcitabine + Oxaliplatin | 02 | N | 260029366 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014378 | 260009713 | 1.83 | 85.3 | Not known (9) | 2016-01-19 | 2016-02-13 | Carboplatin + Etoposide IV 3 day | N | null | 260029368 | BOP |
| 260014379 | 260009714 | 1.69 | 97.2 | Adjuvant (A) | 2017-10-21 | 2017-12-24 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 260029371 | IPILIMUMAB |
| 260014380 | 260009715 | 1.83 | 88.8 | Curative (C) | 2016-05-19 | 2016-05-24 | Cyclophosphamide High Dose | N | null | 260029373 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014381 | 260009716 | 1.81 | null | null | 2013-08-12 | 2013-08-20 | METHOTREXATE | N | null | 260029377 | METHOTREXATE HIGH DOSE |
| 260014382 | 260009717 | 1.63 | 47.8 | Curative (C) | null | 2013-04-10 | Hydroxycarbamide | N | N | 260029378 | REMODL TRIAL |
| 260014383 | 260009718 | 1.63 | 102 | Adjuvant (A) | 2017-10-19 | 2017-10-19 | ESHAP | N | N | 260029384 | IPO |
| 260014384 | 260009719 | 1.72 | 25.3 | Adjuvant (A) | 2015-11-22 | 2015-11-22 | R CODOX-M/ R IVAC | 2 | N | 260029389 | CHOP |
| 260014385 | 260014620 | 1.6 | 77.4 | Curative (C) | null | 2016-10-24 | R IVAC | Y | N | 260029389 | ESHAP R |
| 260014386 | 260009721 | 1.82 | 76 | Curative (C) | 2013-06-20 | 2013-07-18 | GEMCITABINE + VINORELBINE | N | null | 260029410 | IVE |
| 260014387 | 260014621 | 1.73 | 97.7 | Palliative (P) | 2017-07-08 | 2017-07-08 | ESHAP | N | N | 260029416 | ABIRATERONE |
| 260014388 | 260009722 | 1.64 | 56.6 | Curative (C) | null | 2018-11-09 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | Y | 260029416 | CHLORAMBUCIL |
| 260014389 | 260009723 | 1.72 | 78.5 | Disease modification (D) | 2014-12-24 | 2015-01-07 | Bendamustine + Obinutuzumab | N | N | 260029421 | IVE |
| 260014390 | 260009728 | 1.8 | 119 | Disease modification (D) | 2015-07-25 | 2015-07-25 | BEAM + FLUDARABINE | N | N | 260029421 | CYCLOPHOSPHAMIDE |
| 260014391 | 260009729 | 1.88 | 71.4 | Curative (C) | 2014-03-25 | 2014-04-22 | Lenalidomide Cycle 26 onwards (PAS) | N | N | 260029426 | ACE (GERM CELL) |
| 260014392 | 260009729 | null | 50.5 | null | 2014-09-01 | 2014-09-05 | R-PMitCEBOM | N | N | 260029426 | DA |
| 260014393 | 260009731 | 1.67 | 91.5 | Palliative (P) | null | 2016-12-20 | R IVAC | N | N | 260029427 | CYTARABINE HD + METHOTREXATE HD |
| 260014394 | 260009731 | 1.75 | 80 | Disease modification (D) | 2016-12-28 | 2016-12-28 | METHOTREXATE | N | null | 260029427 | PACLITAXEL |
| 260014395 | 260017008 | 1.77 | 81 | Palliative (P) | 2017-08-08 | 2017-08-23 | Methotrexate High Dose (3g/m2) | N | null | 260029440 | ACE (GERM CELL) |
| 260014396 | 260009733 | 1.62 | 77 | Curative (C) | 2018-07-03 | 2018-07-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 260029442 | CHLORAMBUCIL + RITUXIMAB |
| 260014397 | 260009733 | 1.78 | 94.5 | Palliative (P) | 2016-06-12 | 2016-07-02 | Ofatumumab Monthly | N | null | 260029442 | IVE |